Ignite Creation Date:
2024-05-06 @ 9:37 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03020992
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2017-01-11
Brief Title:
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis AU Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
AS0007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Biopharma SRL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None